Contemporary predictors of death and sustained ventricular tachycardia in patients with repaired tetralogy of Fallot enrolled in the INDICATOR cohortAnne Marie Valente, Tal Geva, Kimberlee Gauvreau et al.|Heart|2013Cited by 497
Losartan reduces aortic dilatation rate in adults with Marfan syndrome: a randomized controlled trialMaarten Groenink, B. J. M. Mulder, Anje M. Spijkerboer et al.|European Heart Journal|2013Cited by 396
Effect of Valsartan on Systemic Right Ventricular FunctionTeun van der Bom, Barbara J.M. Mulder, Michiel M. Winter et al.|Circulation|2012Cited by 213
Beneficial Outcome of Losartan Therapy Depends on Type of <i>FBN1</i> Mutation in Marfan SyndromeRomy Franken, Gerard Pals, Alexander W. den Hartog et al.|Circulation Cardiovascular Genetics|2015Cited by 165
The Risk for Type B Aortic Dissection in Marfan SyndromeAlexander W. den Hartog, Maarten Groenink, Romy Franken et al.|Journal of the American College of Cardiology|2015Cited by 153